All filters
Videos
Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases Workshop 2023 - Discussion
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Videos
Monoclonal Antibodies for HIV Prevention - Carlos del Rio
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Videos
Monoclonal Antibodies for HIV—Lessons Learned from COVID-19 - Daniel Kuritzkes
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Videos
Prevention of RSV in Neonates - Natalie Mazur
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Videos
Pharmacological Consideration when using Monoclonal Antibodies (...) - Charles Flexner
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Videos
Management of toxicities from immunotherapy: an ESMO Clinical Practice Guideline - Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPI
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Management of Toxicities from Immunotherapy: an ESMO Clinical Practice Guideline | Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPI
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Videos
Therapeutic Drug Monitoring of Small Molecule Inhibitors in Patient with Lung Cancer: Ready for the Clinic?- Markus Jörger, MD, PhD, ClinPharm
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Therapeutic Drug Monitoring of Small Molecule Inhibitors in Patient with Lung Cancer: Ready for the Clinic? | Markus Jörger, MD, PhD, ClinPharm
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Videos
Drug-Drug Interactions between Small Molecule Inhibitors with Directly-Acting Oral Anti-coagulants (DOACs) in Patients with Lung Cancer. - Lorenz Van der Linden, PharmD, PhD
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Drug-Drug Interactions between Small Molecule Inhibitors with Directly-Acting Oral Anti-coagulants (DOACs) in Patients with Lung Cancer. | Lorenz Van der Linden, PharmD, PhD
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Scientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy | Matthew Gagne
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition
Videos
Paolo Lusso | mRNA Vaccines for HIV
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition
Videos
Matthew Gagne | Scientific Update on mRNA Vaccines for COVID-19 and Implications for Boosting Strategy
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition
Slidesets
Pharmacological Considerations when Using Monoclonal Antibodies for the Treatment and Prevention of Infectious Diseases Implications for Ebola and Clostridium difficile - Flexner.pdf
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Slidesets
Monoclonal Antibodies for HIV—Lessons Learned from COVID-19.pdf
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Slidesets
RSV Prevention in Neonates - Natalie Mazur.pdf
Presented at:
International Workshop on Monoclonal Antibodies for Treatment & Prevention of Infectious Diseases 2023
Slidesets
Vaccines for Respiratory Syncytial Virus | Tracy Ruckwardt
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition
Slidesets
Development of Universal Influenza Vaccines Using Nucleoside-Modified mRNA | Norbert Pardi
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition
Slidesets
Clinical Update on mRNA Vaccines for Flu | M. Anthony Moody
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition
Slidesets
RNA Vaccine Platforms: Activation of Neoantigen Specific T cells for the Treatment of Solid Tumors | Karine Breckpot
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition
Slidesets
Safety Profiles of COVID-19 Vaccines | John R. Su
Presented at:
Leveraging mRNA Technology Workshop - 1st Edition